GARDASIL 9 9-in-1 HPV Vaccine (HPV6, 11, 16, 18, 31, 33, 45, 52, 58)
PhiDerma provides HPV vaccination that prevents approximately 80-90% of cancers and diseases associated with the infection of 9 types of HPV viruses. These include cervical cancer, vulvar cancer, vaginal cancer, anal cancer, head and neck cancers, throat masses, and genital warts. The 9-in-1 HPV vaccine, Gardasil 9, is suitable for females and males aged nine years and older. Ideally, the vaccine should be administered before the onset of sexual activity, but it is also recommended for individuals who are already sexually active or have given birth.
The Gardasil or Gardasil 9 vaccine is administered in three doses within a six-month period. The second dose is given two months after the first dose, and the third dose is administered four months after the second dose.